Important activators of TAK1-dependent receptor-mediated signaling in inflammatory settings—such as spondyloarthropathies—include IL-1 [86], IL-17 [71], TNF-alpha [87] as well as other cytokines. The gene discussed is IL17A; the disease is spondyloarthropathy.